← FDA DRUG APPROVALS

FDA ANDA · ANDA203759

RITONAVIR

Sponsor: CIPLA

APPLICATION
ANDA203759
TYPE
ANDA
ORIGINAL APPROVAL
2022-05-10
LATEST ACTION
2022-05-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

RITONAVIRPrescription
RITONAVIR 100MG · TABLET · ORAL

Approval history

2022-05-10UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →